CVA Family Office’s Stride LRN Stock Holding History

CVA Family Office’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.35K	Buy	38 +31	+443%	+$2.51K	﹤0.01%	1373
2025 Q4	$455	Buy	+7	New	+$636	﹤0.01%	1245

Other funds holding LRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CVA Family Office's LRN Position: Q1 2026 in Review

CVA Family Office increased its Stride (LRN) stake by 443% in Q1 2026, buying an estimated $2.51K and bringing the position to 38 shares worth $3.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1373.

CVA Family Office first reported a position in LRN in Q4 2025 and has held it in 2 quarters since. 419 funds tracked by Wall St. Rank hold LRN as of Q1 2026.

CVA Family Office held 38 shares of Stride worth $3.35K as of Q1 2026.
CVA Family Office bought 31 Stride shares in Q1 2026, an estimated $2.51K.
Stride made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #1373 holding.
CVA Family Office first reported a position in Stride in Q4 2025 and has held it in 2 quarters since.
419 funds tracked by Wall St. Rank held Stride as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.